News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EKR Therapeutics, Inc. Names Two Independent Directors and Reaffirms Board of Directors to Lead Company Growth in the Critical Care Sector


12/15/2011 9:45:16 AM

BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a privately held specialty pharmaceutical company focused on providing critical care products to the hospital marketplace, has announced the appointment of Robert S. Whitehead and Joseph M. Mahady to the EKR Board as Independent Directors. On October 21, 2011, Robert P. Roche, Jr. was previously named as an Independent Director. In addition, all previous Board Members were reelected at EKR’s November 8th Annual Meeting of Stockholders.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES